Domů › Burkittův lymfom › Pennsylvania › Philadelphia
Klinické studie Burkittův lymfom v Philadelphia, PA
16 studií pro Burkittův lymfom hledá účastníky v lokalitách v Philadelphia a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
Probíhá náborFáze 3
- Children's Hospital of Philadelphia (Data Collection Only), Philadelphia
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
Probíhá náborFáze 1
- Children's Hospital of Philadelphia, Philadelphia
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Probíhá náborFáze 2
- Children's Hospital of Philadelphia, Philadelphia
- Saint Christopher's Hospital for Children, Philadelphia
- Alfred I duPont Hospital for Children, Wilmington · Vzdálenost 25 mi
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Probíhá náborFáze 3
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
Blinatumomab Consolidation in Real World
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- University of Pennsylvania, Philadelphia
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Probíhá náborObservační studie
- Children's Hospital of Philadelphia, Philadelphia
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Probíhá náborFáze 2
- Children's Hospital of Philadelphia, Philadelphia
- Alfred I duPont Hospital for Children, Wilmington · Vzdálenost 25 mi
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Probíhá náborFáze 1/2
- Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Probíhá náborFáze 2
- Children's Hospital of Philadelphia, Philadelphia
- Saint Christopher's Hospital for Children, Philadelphia
- Alfred I duPont Hospital for Children, Wilmington · Vzdálenost 25 mi
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Probíhá náborFáze 3
- Children's Hospital of Philadelphia, Philadelphia
- Saint Christopher's Hospital for Children, Philadelphia
- Alfred I duPont Hospital for Children, Wilmington · Vzdálenost 25 mi
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
Probíhá náborFáze 2
- Children's Hospital of Philadelphia, Philadelphia
CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
Probíhá nábor
- Children's Hospital of Philadelphia, Philadelphia
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
Probíhá náborFáze 1/2
- Children's Hospital of Philadelphia, Philadelphia
Co-administration of CART22-65s and huCART19 for B-ALL
Probíhá náborFáze 1/2
- Children's Hospital of Philadelphia, Philadelphia
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Probíhá náborFáze 1/2
- Children's Hospital of Philadelphia, Philadelphia
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
Probíhá náborFáze 2
- Alfred I. duPont Hospital for Children - Nemours Deleware, Wilmington · Vzdálenost 25 mi
Studie Burkittův lymfom v jiných městech
- Houston, TX21 studií
- Milwaukee, WI16 studií
- Chicago, IL15 studií
- Cincinnati, OH13 studií
- New York City, NY13 studií
- Atlanta, GA12 studií
- Aurora, CO11 studií
- Seattle, WA11 studií
- Durham, NC10 studií
- Boston, MA10 studií
- Kansas City, MO10 studií
- Los Angeles, CA10 studií
Další studie v Philadelphia
- Rakovina (všechny typy)59 studií
- Rakovina prsu56 studií
- Nemalobuněčný plicní karcinom51 studií
- Metastatický karcinom46 studií
- Rakovina prostaty44 studií
- Kolorektální karcinom44 studií
- Rakovina vaječníků44 studií
- Rakovina plic36 studií
- Akutní myeloidní leukemie34 studií
- Srdeční selhání31 studií
- Rakovina endometria28 studií
- Deprese26 studií
Zdroj: ClinicalTrials.gov, data načtena 6. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.